Go back to the main page.
Transforming Today's Science Into Tomorrow's Cures
Samaritan's collaborative researchers have made important patented discoveries in the fields of, central nervous system diseases, such as, Alzheimer's disease; cancer; cardiovascular disease; and infectious diseases, such as, AIDS, and Hepatitis C. These discoveries have positioned us with a rich pipeline of new drugs with novel mechanisms of actions to develop.
Samaritan Pharmaceuticals, Inc. is an entrepreneurial biopharmaceutical company focused on the development and marketing of innovative therapeutics. At Samaritan Pharmaceuticals our mission has been to create life-saving drugs for people suffering from AIDS, Alzheimer’s, heart disease and cancer. View all the latest press releases and news articles focused on Samaritan Pharmaceuticals, Inc. These publications, called peer-reviewed journals, are scholarly periodicals requiring each article submitted be judged by an independent panel of experts (scientific peers) to authenticate the accuracy of the material. The number of articles printed and the variety of publications accepting the article serve to underscore the legitimacy of information. Samaritan has collaborative relationships with other pharmaceutical companies to commercialize branded approved prescription products in selected niche territories, such as, in Greece, Albania, Bosnia, Bulgaria, Croatia, Cyprus, Czech Republic, Egypt, FYROM, Hungary, Montenegro, Poland, Romania, Serbia, Slovakia, Slovania, Syria and Turkey. Before a drug can be offered to the public it must go through several phases of rigorous testing to make sure it is safe, efficient and does what it says it can do. The testing is mandated and overseen by the U.S. Food and Drug Administration (FDA) which is part of the U.S. Department of Health and Human Services. SAMARITAN PIPELINE - (MECHANISM OF ACTION VIDEOS)
Go back to the main page. Contact Samaritan Pharmaceuticals, Inc. Find what you are looking for in our website.
EXECUTIVE BIOGRAPHIES

Dr. Laurent Lecanu
Director

Dr. Laurent Lecanu is Assistant Professor at Georgetown University Medical Center, Department of Biochemistry and Molecular Biology and Head of the Samaritan Research Laboratories. He has a M.Sc. in Pharmacochemistry, a M.Sc. in Clinical Pharmacokinetic, a M.Sc. in Experimental and Clinical Pharmacology and holds a DPharm and a PhD in Neuropharmacology from the University of Paris, France.

Dr. Lecanu has also been a resident in internal medicine and in clinical pharmacy for four years in Paris hospitals. He has 11 years of experience in neurosciences and biopharmaceutical research and several patents in neurosciences field. In 2001, Dr. Lecanu was awarded, by the French National Academy of Pharmacy, the Prize of the French Association for the Therapeutic Research for his research work on the neuronal death during cerebral ischaemia.

Back to Board of Directors

Back to Science and Technology Advisory Committee

Partnering
Opportunities